Nabil Enattah

Title: Nabil Enattah: Innovator in Genetic Research

Introduction

Nabil Enattah is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of genetic research, particularly in understanding adult-type hypolactasia. His work has led to the development of innovative diagnostic methods that can aid in the detection of this condition.

Latest Patents

Nabil Enattah holds 2 patents related to his research. His latest patents focus on the identification of a DNA variant associated with adult-type hypolactasia. The inventions involve a nucleic acid molecule that comprises a 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene. This gene is indicative of adult-type hypolactasia. The patents also describe methods for testing for the presence of or predisposition to this condition, based on the analysis of a single nucleotide polymorphism (SNP) contained in the nucleic acid molecule. Additionally, the inventions include diagnostic compositions and kits useful for detecting the presence of or predisposition to adult-type hypolactasia.

Career Highlights

Nabil Enattah is affiliated with the National Public Health Institute, where he conducts his research. His work has been instrumental in advancing the understanding of lactose intolerance and its genetic basis.

Collaborations

He has collaborated with notable colleagues, including Leena Peltonen and Timo Sahi, to further his research efforts and enhance the impact of his findings.

Conclusion

Nabil Enattah's contributions to genetic research, particularly in the area of adult-type hypolactasia, highlight his role as an innovator in the field. His patents and collaborations reflect a commitment to advancing medical science and improving diagnostic methods.